Showing results (151-160 of 464) with videos related to

Sort By:
Pageof 47
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell linesRaluca T Tavaluc, Lori S Hart, David T Dicker, et al.
Cancer Biology & Therapy|August 13, 2002
Clinical and molecular features of small cell lung cancerAllyson M Campbell, Barbara G Campling, Kenneth M Algazy, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2017
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaJun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 24, 2018
Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanismsJessica Wagner, C Leah Kline, Lanlan Zhou, et al.
International Journal of Oncology|June 19, 1998
p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cellsN S Prabhu, K Somasundaram, K Satyamoorthy, et al.
Cancer Research|February 26, 2015
Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent MannerVarun V Prabhu, Joshua E Allen, David T Dicker, et al.
Cancer Biology & Therapy|February 20, 2015
A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastasesEric Marks, Syed Mujtaba Rizvi, Nabeel Sarwani, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine differentiation (ND) in sensitivity of neuroendocrine tumor (NET) cells to ONC201/TIC10 cancer therapeuticElizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, et al.
The Journal of Biological Chemistry|July 8, 2000
Repression of BRCA1 through a feedback loop involving p53T K MacLachlan, B C Dash, D T Dicker, et al.
Frontiers in Pharmacology|November 5, 2021
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer TherapeuticsAnna D Louie, Kelsey Huntington, Lindsey Carlsen, et al.
Pageof 47